• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Environmental Impact Acquisition corp. Files Proxy Statement/Prospectus For Feb 1, 2022 Special Meeting To Approve Proposed Business Combo With GreenLight Bio

    1/14/22 10:31:37 AM ET
    $ENVI
    Get the next $ENVI alert in real time by email

    Environmental Impact Acquisition Corporation (NASDAQ:ENVI) ("ENVI"), a publicly-traded special purpose acquisition company, announced today that ENVI's definitive proxy statement/prospectus (the "Proxy Statement") relating to the previously announced business combination with GreenLight Biosciences, Inc. ("GreenLight"), a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, has been filed with the U.S. Securities and Exchange Commission (the "SEC") on January 13, 2022.

    GreenLight's breakthrough cell-free RNA manufacturing platform allows for cost-effective production of RNA.

    ENVI has commenced mailing of the Proxy Statement and a notice and voting instruction form or a proxy card relating to the special meeting of ENVI stockholders (the "Special Meeting") to ENVI stockholders of record as of the close of business on December 29, 2021 (the "Record Date"), who will be entitled to attend and participate in the Special Meeting.

    The Special Meeting to approve the proposed business combination and related matters is scheduled to be held on February 1st, 2022 at 9:00 A.M. Eastern time. The Special Meeting will be conducted completely virtually, and can be accessed via live webcast at www.virtualshareholdermeeting.com/ENVI2022SM. If the proposals at the Special Meeting are approved, the parties anticipate that the business combination will close and the trading of the combined entity will commence on NASDAQ shortly thereafter, subject to the satisfaction or waiver, as applicable, of all other closing conditions.

    The ENVI Board of Directors believes the proposed business combination is in the best interests of ENVI and its stockholders, and recommends that ENVI stockholders vote "FOR" the adoption and approval of the Business Combination Agreement, dated as of August 10, 2021 (as amended by the First Amendment to the Business Combination Agreement, dated July 27, 2021), by and among ENVI, GreenLight, as well as all other proposals included in ENVI's Proxy Statement.

    Every stockholder's vote is important, regardless of the number of shares held. Accordingly, ENVI requests that each stockholder complete, sign, date and return a proxy card (online or by mail) as soon as possible so that their votes arrive no later than 11:59 P.M. on January 31, 2022, to ensure that the stockholder's shares will be represented at the Special Meeting. Stockholders that hold shares in "street name" (i.e., those stockholders whose shares are held of record by a broker, bank or other nominee) should contact their broker, bank or nominee to provide instructions on how to vote their shares and ensure that their shares are voted.

    If any individual ENVI stockholder does not receive the Proxy Statement, such stockholder should (i) confirm their Proxy Statement's status with their broker or (ii) contact D.F. King, ENVI's proxy solicitor, for assistance via e-mail at [email protected] or toll-free call at (866) 620-2535. Banks and brokers can place a collect call to (212) 269-5550.

    ENVI expects to provide stockholders with additional information on how stockholders may vote their shares on its website in the coming days.

    Get the next $ENVI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ENVI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ENVI
    SEC Filings

    View All

    SEC Form 425 filed by Environmental Impact Acquisition Corp.

    425 - Environmental Impact Acquisition Corp (0001822691) (Subject)

    2/2/22 8:34:52 AM ET
    $ENVI

    Environmental Impact Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Environmental Impact Acquisition Corp (0001822691) (Filer)

    2/2/22 8:32:05 AM ET
    $ENVI

    SEC Form 425 filed by Environmental Impact Acquisition Corp.

    425 - Environmental Impact Acquisition Corp (0001822691) (Subject)

    1/28/22 9:10:59 AM ET
    $ENVI

    $ENVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Walker Matthew Alan was granted 14,343,021 shares and bought $15,000,000 worth of shares (1,500,000 units at $10.00)

    4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

    2/4/22 8:22:17 PM ET
    $ENVI

    SEC Form 3 filed by new insider Walker Matthew Alan

    3 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

    2/4/22 8:20:21 PM ET
    $ENVI

    SEC Form 4 filed by Keefe Susan

    4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

    2/4/22 8:01:51 PM ET
    $ENVI

    $ENVI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GreenLight Biosciences begins trading today as Nasdaq: GRNA on the closing of its business combination with Environmental Impact Acquisition Corp.

    BOSTON, Feb. 3, 2022 /PRNewswire/ -- GreenLight Biosciences ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp. (NASDAQ:ENVI) ("ENVI"), a special purpose acquisition company, yesterday announced the closing of their previously announced business combination. In connection with the closing, the company changed its name to GreenLight Biosciences Holdings, public-benefit corporation, with shares of Class A common stock and public warrants

    2/3/22 10:02:00 AM ET
    $ENVI

    Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022

    BOSTON, Feb. 2, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ:ENVI), a publicly-traded special purpose acquisition company, announced today that its business combination with Greenlight Biosciences was approved in a shareholder vote held yesterday, with 80.7% of shareholders participating in the vote and 78.6% voting in favor of the combination. Subject to the satisfaction or waiver of the other customary closing conditions, Environmental Impact Acquisition Corp. anticipates closing the business combination today. In connection with the closing, the

    2/2/22 8:58:00 AM ET
    $ENVI

    GreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control Pests

    BOSTON, Jan. 31, 2022 /PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership agreement that could lead to the first commercial use of RNA as a seed treatment to control crop diseases and offer options to farmers looking for innovative solutions. Through the partnership, the two companies will explore synergies between Germains' seed priming and coating technologies and GreenLight's dsRNA expertise and ability to cost-effectively scale manufacturing to protect vegetable crops

    1/31/22 10:40:00 AM ET
    $ENVI

    $ENVI
    Leadership Updates

    Live Leadership Updates

    View All

    Greenlight Biosciences (ENVI) Adds Two World-Renowned Scientists To Its Scientific Advisory Board

    BOSTON, Nov. 4, 2021 /PRNewswire/ -- GreenLight Biosciences is delighted to announce the appointment of Professor Diane E. Griffin, MD, PhD, and Emmanuel Hanon, DVM, PhD, to its Human Health Scientific Advisory Board. At Johns Hopkins University, Diane Griffin is the Distinguished Service Professor, a professor of Medicine and Neurology at the School of Medicine, and the W. Harry Feinstone professor at the Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health. She has also been vice president of the U.S. National Academy of Sciences since

    11/4/21 10:02:00 AM ET
    $ENVI

    GreenLight Biosciences Announces the Appointment of Jennifer Raymond As SVP, CMC and Manufacturing

    BOSTON, Sept. 16, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, announced the appointment of Jennifer Raymond as SVP, CMC & Manufacturing today. Raymond joins GreenLight from GSK with more than 23 years of experience in the pharmaceutical industry, including 13 years in vaccines development, production, and Quality Assurance, across Merck, Novartis, and GSK. She has comprehensive first-hand experience in both R&D and Operations in small and large scale biological platforms (mammalian, viral, bacterial). Raymond's recent work includes development and launch of specialty biophar

    9/16/21 12:02:00 PM ET
    $ENVI

    $ENVI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Environmental Impact Acquisition Corp.

    SC 13G - Environmental Impact Acquisition Corp (0001822691) (Subject)

    7/6/21 5:19:57 PM ET
    $ENVI